Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
11,425,219
-
Shares change
-
+29,927
-
Total reported value, excl. options
-
$112,817,466
-
Value change
-
+$259,064
-
Number of buys
-
16
-
Number of sells
-
16
-
Price
-
$9.89
Institutional Holders of MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) as of Q4 2021
As of 31 Dec 2021 MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,425,219 shares of stock of the company.
Largest 10 holders included FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., CITADEL ADVISORS LLC, 683 Capital Management, LLC, STALEY CAPITAL ADVISERS INC, MARSHALL WACE, LLP, Cormorant Asset Management, LP, and BOXER CAPITAL, LLC.
This table shows 45 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.